|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 13, 2018 ) According to Publisher, the Global Biopreservation Market is accounted for $2.17 billion in 2015 and is expected to reach $4.75 billion by 2022 growing at a CAGR of 11.84% during the forecast period. Rising healthcare costs, improved research and development in the field and rising usage of regenerative medicine are some of the factors boosting the market growth. However, huge cost of advanced techniques is one of the key factors hampering the market.
For more information http://www.reportsweb.com/biopreservation-global-market-outlook-2016-2022
By cell provider’s volume, Tumor cells segment dominated the global market with largest share in 2014 due to several applications in research & development. By geography, North America dominated the global market with more than 40% of the share in 2014 owing to therapies in biomedical research and rise in the population requiring diagnosis in this region. However, the Asia-Pacific market is anticipated to grow at the fastest CAGR during the forecast period.
Some of the key players in Biopreservation market include Qiagen N.V., Biolife Solutions, Inc., Lifeline Scientific, Inc., Biomatrica, Inc., Taylor-Wharton Cryogenics LLC, Custom Biogenic Systems, Inc., BioCision, LLC, Sigma-Aldrich Corporation, Cesca Therapeutics Inc., Atlanta Biologicals Inc, Princeton CryoTech Inc., VWR Corporation, Core Dynamics Ltd, So-Low Environmental Equipment Co., Inc., LABVANTAGE Solutions, Inc., Biogenics, Thermo Fisher Scientific and Panasonic Corporation.
Applications Covered:
- Bio-banking
o Human sperms
o Human eggs
o Veterinary IVF
- Regenerative Medicine
o Gene therapy
o Cell therapy
o Other Regenerative Medicines
- Drug Discovery
- Other Applications
Biospecimens Covered:
- Stem Cells
- Human Tissue Samples
- Organs
- Other Biospecimens
Products Covered:
- Media
o Nutrient Media
o Pre-formulated
o Growth Factors and Supplements
o Home-brew
o Sera
- Laboratory Information Management System (LIMS)
- Equipment
o Incubators
o Consumables
o Centrifuges
o Temperature Control Systems
o Accessories
o Liquid Nitrogen (LN2) Tanks
o Other Equipments
Cell Providers Volumes Covered:
- Mesenchymal Stem Cells (MSC)
- CD34+ cells
- Tumor cells
- Induced Pluripotent Stem Cells (iPSC)
- CD19+ cells
- Human Embryonic Stem Cells (hESC)
- Other Cell Providers Volumes
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564980/sample
End Users Covered:
- Hospitals
- Biobanks
- Gene Banks
- Other End Users
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
12 Company Profiling
12.1 Qiagen N.V.
12.2 Biolife Solutions, Inc.
12.3 Lifeline Scientific, Inc.
12.4 Biomatrica, Inc.
12.5 Taylor-Wharton Cryogenics LLC
12.6 Custom Biogenic Systems, Inc.
12.7 BioCision, LLC
12.8 Sigma-Aldrich Corporation
12.9 Cesca Therapeutics Inc.
12.10 Atlanta Biologicals Inc
12.11 Princeton CryoTech Inc.
12.12 VWR Corporation
12.13 Core Dynamics Ltd
12.14 So-Low Environmental Equipment Co., Inc.
12.15 LABVANTAGE Solutions, Inc.
12.16 Biogenics
12.17 Thermo Fisher Scientific
12.18 Panasonic Corporation
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564980/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
